A method that could lead to a safe and effective aerosol vaccine to prevent COVID-19 and to treat other respiratory infections has been identified by investigators at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School. “Targeted pulmonary delivery is needle-free and minimally invasive, an attribute particularly relevant in the administration of multi-dose vaccines or other molecules. Also, because the lungs are constantly being exposed to pathogens from the air, they have a high level of immune defense activity, and therefore may represent an efficient site for complete immune protection against airborne pathogens,” said co-corresponding author Wadih Arap, director of Rutgers Cancer Institute of New Jersey at University Hospital and chief of the Division of Hematology/Oncology at Rutgers New Jersey Medical School. To read the full story.
Home / News / Rutgers Research Identifies Safe and Effective Method of Delivering Medicines to the Lungs
Recent Posts
- NIH Fellowship Writing Group: Call for Applications – Sign Up by 8/25
- Join The National Clinical Cohort Collaborative (N3C) Community Forum on 7/30
- NIH Fellowship Writing Group: Call for Applications – Sign Up by 8/25
- Rutgers Students Showcase AI-Driven Research Success Through NJ ACTS Summer Research Program
- Rutgers NJHealth Study Data Access Opportunity – Application Due July 6th!
Categories
- Community (2,500)
- Covid (1,001)
- CTO Events (6)
- News (3,174)
- Pilots (21)